2006
DOI: 10.1038/sj.gt.3302811
|View full text |Cite
|
Sign up to set email alerts
|

Intravenously administered oligonucleotides can be delivered to conducting airway epithelium via the bronchial circulation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2007
2007
2021
2021

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 34 publications
0
3
0
Order By: Relevance
“…Whether or not this method of administration may result in a therapeutic effect in relevant CF animal models has to be demonstrated. Using the bronchial circulation might be another approach and has already been exploited for gene-therapy vectors [20]. The systemic route would be significant only if the role of alveolar epithelium and macrophages in the pathogenesis of CF lung disease is clarified.…”
Section: Expert Commentarymentioning
confidence: 99%
“…Whether or not this method of administration may result in a therapeutic effect in relevant CF animal models has to be demonstrated. Using the bronchial circulation might be another approach and has already been exploited for gene-therapy vectors [20]. The systemic route would be significant only if the role of alveolar epithelium and macrophages in the pathogenesis of CF lung disease is clarified.…”
Section: Expert Commentarymentioning
confidence: 99%
“…This information, together with our present knowledge of protamine structure and function and advances in transgene technology, make it possible to test directly how specific changes in protamine structure (for example, the removal of phosphorylation sites, changes in P2 processing sites or removal of functional thiols and zinc-coordinating residues) and sperm chromatin composition impact on protamine function, chromatin packaging, male fertility and the progression of early embryogenesis. We have also learned enough about how protamine functions to create small synthetic DNA-binding proteins or peptides for use in packaging, protecting and aiding the delivery of functional genes to selected cell populations for use in gene therapy [ 76 - 78 ], gene silencing [ 79 ] or in targeting toxic genes to tumor cells [ 80 ]. The self-assembling nature of the protamine-DNA complex may also provide a new approach that can be used to create nanometer- to micrometer-scale self-assembling electrically conductive polymers for use in constructing biocompatible electrical circuits.…”
Section: Frontiersmentioning
confidence: 99%
“…Due to the high affinity to DNA backbone, the positivecharged PRMs, especially PRM1, is found to be great help in facilitating the development of novel gene carriers to selected cell populations (25)(26)(27)(28)(86)(87)(88). Lately, Weide et al developed a more feasible and safe method to deliver tumor vaccine.…”
Section: Novel Vector For Drug Delivery Systemmentioning
confidence: 99%